Biosimilars for anti-VEGF treatment of macular diseases: country and region reports.
Saved in:
| Title: | Biosimilars for anti-VEGF treatment of macular diseases: country and region reports. |
|---|---|
| Authors: | Cano M; Head of Ophthalmology: Catholic University of Asunción School of Medicine, Asunción, Paraguay., Dhanapala M; Consultant Vitreo-Retinal Surgeon: Retina Research Unit, National Eye, Colombo, Sri Lanka., Kang M; Ophthalmologist: Tongren Hospital, Beijing, China., Piyasena MP; Deputy Director: Vision and Eye Research Institute, Faculty of Health, Medicine and Social Care, Anglia Ruskin University, UK., Raman R; Professor: Medical Research Foundation, Sankara Nethralaya & Indian Institute of Technology, Madras, Chennai, India., Yorston D; Consultant Ophthalmologist, Tennent Institute of Ophthalmology, Gartnavel Hospital, Glasgow, Scotland. |
| Source: | Community eye health [Community Eye Health] 2025; Vol. 37 (125), pp. 22-23. Date of Electronic Publication: 2025 Jan 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Centre for Eye Health Country of Publication: England NLM ID: 8912615 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0953-6833 (Print) Linking ISSN: 09536833 NLM ISO Abbreviation: Community Eye Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
